» Articles » PMID: 8626650

Involvement of the Switch 2 Domain of Ras in Its Interaction with Guanine Nucleotide Exchange Factors

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1996 May 10
PMID 8626650
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

While Ras proteins are activated by stimulated GDP release, which enables acquisition of the active GTP-bound state, little is known about how guanine nucleotide exchange factors (GEFs) interact with Ras to promote this exchange reaction. Here we report that mutations within the switch 2 domain of Ras (residues 62-69) inhibit activation of Ras by the mammalian GEFs, Sos1, and GRF/CDC25Mm. While mutations in the 62-69 region blocked upstream activation of Ras, they did not disrupt Ras effector functions, including transcriptional activation and transformation of NIH 3T3 cells. Biochemical analysis indicated that the loss of GEF responsiveness of a Ras(69N) mutant was due to a loss of GEF binding, with no change in intrinsic nucleotide exchange activity. Furthermore, structural analysis of Ras(69N) using NMR spectroscopy indicated that mutation of residue 69 had a very localized effect on Ras structure that was limited to alpha-helix 2 of the switch 2 domain. Together, these results suggest that the switch 2 domain of Ras forms a direct interaction with GEFs.

Citing Articles

The ribosome lowers the entropic penalty of protein folding.

Streit J, Bukvin I, Chan S, Bashir S, Woodburn L, Wlodarski T Nature. 2024; 633(8028):232-239.

PMID: 39112704 PMC: 11374706. DOI: 10.1038/s41586-024-07784-4.


A saturation-mutagenesis analysis of the interplay between stability and activation in Ras.

Hidalgo F, Nocka L, Shah N, Gorday K, Latorraca N, Bandaru P Elife. 2022; 11.

PMID: 35272765 PMC: 8916776. DOI: 10.7554/eLife.76595.


Identification of the nucleotide-free state as a therapeutic vulnerability for inhibition of selected oncogenic RAS mutants.

Khan I, Koide A, Zuberi M, Ketavarapu G, Denbaum E, Teng K Cell Rep. 2022; 38(6):110322.

PMID: 35139380 PMC: 8936000. DOI: 10.1016/j.celrep.2022.110322.


A Rational Design of α-Helix-Shaped Peptides Employing the Hydrogen-Bond Surrogate Approach: A Modulation Strategy for Ras-RasGRF1 Interaction in Neuropsychiatric Disorders.

Gulotta M, Brambilla R, Perricone U, Brancale A Pharmaceuticals (Basel). 2021; 14(11).

PMID: 34832880 PMC: 8623491. DOI: 10.3390/ph14111099.


The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors.

Gebregiworgis T, Kano Y, St-Germain J, Radulovich N, Udaskin M, Mentes A Nat Commun. 2021; 12(1):6274.

PMID: 34725361 PMC: 8560773. DOI: 10.1038/s41467-021-26526-y.